{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:52:13Z","timestamp":1789599133038,"version":"build-2803163510"},"reference-count":25,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2019,4,8]]},"DOI":"10.3233\/jad-181146","type":"journal-article","created":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T13:43:51Z","timestamp":1552398231000},"page":"1061-1069","source":"Crossref","is-referenced-by-count":8,"title":["Assessment of 18F-Florbetaben Amyloid PET Imaging in Patients with Suspected Alzheimer\u2019s Disease and Isolated Increase in Cerebrospinal Fluid Tau Proteins"],"prefix":"10.1177","volume":"68","author":[{"given":"Chlo\u00e9","family":"Manca","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU-Nancy, Lorraine University, Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Hopes","sequence":"additional","affiliation":[{"name":"Department of Neurology, CHRU-Nancy, Lorraine University, Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kearney-Schwartz","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, CHRU-Nancy, Lorraine University, Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Roch","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU-Nancy, Lorraine University, Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Karcher","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU-Nancy, Lorraine University, Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Baumann","sequence":"additional","affiliation":[{"name":"CHRU-Nancy, Methodological and Biostatistical Support Unit, Platform of Clinical Research Support PARC, Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Yves","family":"Marie","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU-Nancy, Lorraine University, Nancy, France"},{"name":"INSERM, Lorraine University, DCAC, Nancy, INSERM U1116, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Malaplate-Armand","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, CHRU-Nancy, Lorraine University, Molecular Biology and Nutrition, Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e9r\u00e8se Rivasseau","family":"Jonveaux","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, CHRU-Nancy, Lorraine University, Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Verger","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU-Nancy, Lorraine University, Nancy, France"},{"name":"IADI, INSERM, Lorraine University, Nancy, INSERM U1254, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-181146_ref1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-181146_ref2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3233\/JAD-131838","article-title":"Additional use of A\u03b242\/A\u03b240 ratio with cerebrospinal fluid biomarkers P-tau and A\u03b242 increases the level of evidence of Alzheimer\u2019s disease pathophysiological process in routine practice","volume":"41","author":"Sauv\u00e9e","year":"2014","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.3233\/JAD-181146_ref3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3233\/JAD-121549","article-title":"Impact of the 2008-2012 French Alzheimer Plan on the use of cerebrospinal fluid biomarkers in research memory center: The PLM Study","volume":"34","author":"Gabelle","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-181146_ref4","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-181146_ref5","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jalz.2015.02.004","article-title":"Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer\u2019s disease: Phase 3 study","volume":"11","author":"Sabri","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-181146_ref6","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/jamaneurol.2014.1358","article-title":"Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid \u03b2-amyloid 42: A cross-validation study against amyloid positron emission tomography","volume":"71","author":"Palmqvist","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-181146_ref7","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3233\/JAD-132561","article-title":"Concordance between cerebrospinal fluid biomarkers and [11C]PIB PET in a memory clinic cohort","volume":"41","author":"Zwan","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-181146_ref8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jalz.2017.09.009","article-title":"Added value of 18F-florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study","volume":"14","author":"Ceccaldi","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-181146_ref9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13195-016-0228-4","article-title":"Diagnostic impact of [18F]flutemetamol PET in early-onset dementia","volume":"9","author":"Zwan","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-181146_ref10","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/jamaneurol.2016.3751","article-title":"Assessment of the incremental diagnostic value of Florbetapir F 18 imaging in patients with cognitive impairment: The Incremental Diagnostic Value of Amyloid PET with [18F]-Florbetapir (INDIA-FBP) Study","volume":"73","author":"Boccardi","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-181146_ref11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000441139","article-title":"Effect of amyloid imaging on the diagnosis and management of patients with cognitive decline: Impact of appropriate use criteria","volume":"41","author":"Grundman","year":"2016","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-181146_ref12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/WAD.0b013e318279d02a","article-title":"Potential impact of amyloid imaging on diagnosis and intended management in patients with progressive cognitive decline","volume":"27","author":"Grundman","year":"2013","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-181146_ref13","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.3233\/JAD-151180","article-title":"Clinical utility of amyloid PET imaging in the differential diagnosis of atypical dementias and its impact on caregivers","volume":"52","author":"Bensa\u00efdane","year":"2016","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.3233\/JAD-181146_ref14","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (DSM-5\u00ae). American Psychiatric Publishing, Washington, DC.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"10.3233\/JAD-181146_ref15","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.3233\/JAD-181146_ref16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3233\/JAD-160865","article-title":"Cerebrospinal fluid A\u03b242\/A\u03b240 as a means to limiting tube- and storage-dependent pre-analytical variability in clinical setting","volume":"57","author":"Gervaise-Henry","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-181146_ref18","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer\u2019s disease: The IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-181146_ref19","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1468-1331.2010.03040.x","article-title":"EFNS guidelines for the diagnosis and management of Alzheimer\u2019s disease","volume":"17","author":"Hort","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.3233\/JAD-181146_ref20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40336-015-0102-6","article-title":"Beta-amyloid imaging with florbetaben","volume":"3","author":"Sabri","year":"2015","journal-title":"Clin Transl Imaging"},{"key":"10.3233\/JAD-181146_ref21","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): Current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"10.3233\/JAD-181146_ref22","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1016\/j.jalz.2013.01.002","article-title":"Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer\u2019s Association","volume":"9","author":"Johnson","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-181146_ref23","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2967\/jnumed.113.127068","article-title":"Update on appropriate use criteria for amyloid PET imaging: Dementia experts, mild cognitive impairment, and education","volume":"54","author":"Johnson","year":"2013","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-181146_ref24","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jalz.2012.07.003","article-title":"Impact of molecular imaging on the diagnostic process in a memory clinic","volume":"9","author":"Ossenkoppele","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-181146_ref25","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/brain\/awu367","article-title":"Independent information from cerebrospinal fluid amyloid-\u03b2 and florbetapir imaging in Alzheimer\u2019s disease","volume":"138","author":"Mattsson","year":"2015","journal-title":"Brain"},{"key":"10.3233\/JAD-181146_ref26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrneurol.2015.251","article-title":"Suspected non-Alzheimer disease pathophysiology\u2014concept and controversy","volume":"12","author":"Jack","year":"2016","journal-title":"Nat Rev Neurol"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-181146","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:09:20Z","timestamp":1777370960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.medra.org\/servlet\/aliasResolver?alias=iospress&doi=10.3233\/JAD-181146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,8]]},"references-count":25,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-181146","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,8]]}}}